Age may alter vaccine immunity: new study investigates

NCT ID NCT04852289

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the immune systems of younger and older adults respond to Pfizer or Moderna COVID-19 vaccines. Researchers will collect blood samples from 78 healthy volunteers over two years to measure specific T-cell responses. The goal is to understand if age changes how well the vaccine works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how age impacts immune response to COVID-19 vaccines, helping improve future vaccine strategies.

What could go wrong

This is an observational study, not a treatment trial. It only measures immune markers and may not lead to direct health changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NIH/NIA/Biomedical Research Center at Johns Hopkins Bayview campus

    Baltimore, Maryland, 21244, United States

  • National Institute of Aging, Clinical Research Unit

    Baltimore, Maryland, 21224, United States